High-level constitutive expression of α1-acid glycoprotein and lack of protection against tumor necrosis factor-induced lethal shock in transgenic mice

Transgenic Research

Volumn 7, Issue 6, 1998, Pages 429-435

  Libert, Claude ^a   Hochepied, Tino ^a   Berger, Franklin G ^b   Baumann, Heinz ^c   Fiers, Walter ^a   Brouckaert, Peter ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Acute phase; Cytokines; Hepatitis; Transgenic

Indexed keywords

GALACTOSAMINE; HETEROZYGOTE; HOMOZYGOTE; INTERLEUKIN 1; LIVER CELL; OROSOMUCOID; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SHOCK; TRANSGENIC MOUSE; TUMOR NECROSIS FACTOR;

ACUTE-PHASE REACTION; ANIMALS; CATTLE; FEMALE; GALACTOSAMINE; HEPATITIS, ANIMAL; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; OROSOMUCOID; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BOVINAE; MUS MUSCULUS; RODENTIA;

EID: 0032214997     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008810429645     Document Type: Article

References (26)

1. Baumann, H. (1988) Electrophoretic analysis of acute-phase plasma proteins. Methods Enzymol. 163, 566-94.
2. Baumann, H. and Gauldie, J. (1994) The acute phase response. Immunol. Today 15, 74-80.
3. Brouckaert, P.G.G., Leroux-Roels, G.G., Guisez, Y., Tavernier, J. and Fiers, W. (1986) in vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma. Int. J. Cancer 38, 763-69.
4. 1-acid glycoprotein. Protein Expression Purification 2, 34-6.
5. Costello, M., Fiedel, B.A. and Gewurz, H. (1979) Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein. Nature 281, 677-78.
6. Decker, K. and Keppler, D. (1974) Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71, 77-106.
7. Dewey, M.J., Rheaume, C., Berger, F.G. and Baumann, H. (1990) Inducible and tissue-specific expression of rat α-1-acid glycoprotein in transgenic mice. J. Immunol. 144, 4392-98.
8. 1-acid glycoprotein: structure and possible functions in the acute phase response. In Mackiewicz, A., Kushner, I. and Baumann, H. eds., Acute Phase Proteins. Molecular Biology, Biochemistry, and Clinical Applications, pp. 107-16. Boca Raton: CRC Press.
9. Fiers, W. (1995) Biologic therapy with TNF: preclinical studies. In DeVita Jr., V.T., Hellman, S. and Rosenberg, S.A. eds., Biologic Therapy of Cancer, 2nd ed., pp. 295-327. Philadelphia: J.B. Lippincott.
10. Fransen, L., Van der Heyden, J., Ruysschaert, R. and Fiers, W. (1986) Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell lines. Eur. J. Cancer Clin. Oncol. 22, 419-26.
11. Kettelhut, I.C., Fiers, W. and Goldberg, A.L. (1987) The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc. Natl. Acad. Sci. USA 84, 4273-7.
12. 1-acid glycoprotein. Inflammation 14, 1-9.
13. Lehmann, V., Freudenberg, M.A. and Galanos, C. (1987) Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165, 657-63.
14. Leist, M., Gantner, F., Jilg, S. and Wendel, A. (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154, 1307-16.
15. Lejeune, F., Liénard, D., Eggermont, A., Schraffordt Koops, H., Kroon, B., Gérain, J., Rosenkaimer, F. and Schmitz, P. (1994) Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. Circ. Shock 43, 191-7.
16. Libert, C., Van Bladel, S., Brouckaert, P. and Fiers, W. (1991a) The influence of modulating substances on tumor necrosis factor and interleukin-6 levels after injection of murine tumor necrosis factor or lipopolysaccharide in mice. J. Immunother. 10, 227-35.
17. Libert, C., Van Bladel, S., Brouckaert, P., Shaw, A. and Fiers, W. (1991b) Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor. J. Immunol. 146, 2625-32.
18. 1-acid glycoprotein against tumor necrosis factor-induced lethality. J. Exp. Med. 180, 1571-5.
19. 1-Antitrypsin inhibits the lethal response to TNF in mice. J. Immunol. 157, 5126-9.
20. Libert, C., Van Molle, W., Brouckaert, P. and Fiers, W. (1996b) Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality. J. Inflam. 46, 139-43.
21. Macintyre, S., Samols, D. and Dailey, P. (1994) Two carboxylesterases bind C-reactive protein within the endoplasmic reticulum and regulate its secretion during the acute phase response. J. Biol. Chem. 269, 24496-503.
22. McNamara, P.J., Brouwer, K.R. and Gillespie, M.N. (1986) Autocoid binding to serum proteins. Interaction of platelet-activating factor (PAF) with human serum alpha-1-acid glycoprotein (AAG). Biochem. Pharmacol. 35, 621-24.
23. Pevsner, J., Reed, R.R., Feinstein, P.G. and Snyder, S.H. (1988) Molecular cloning of odorant-binding protein: member of a ligand carrier family. Science 241, 336-9.
24. Schnitzer, J.E. and Pinney, E. (1992) Quantitation of specific binding of orosomucoid to cultured microvascular endothelium: role in capillary permeability. Am. J. Physiol. 263, H48-H55.
25. Takahashi, N., Brouckaert, P. and Fiers, W. (1991) Induction of tolerance allows separation of lethal and antitumor activities of tumor necrosis factor in mice. Cancer Res. 51, 2366-72.
26. 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J. Immunol. 159, 3555-64.